Cancer Institute A national cancer institute
designated cancer center

Ronald Levy, MD

Publication Details

  • SYNTHETIC PEPTIDE LIGANDS OF THE ANTIGEN-BINDING RECEPTOR INDUCE PROGRAMMED CELL-DEATH IN A HUMAN B-CELL LYMPHOMA PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA Renschler, M. F., Bhatt, R. R., Dower, W. J., Levy, R. 1994; 91 (9): 3623-3627

    Abstract:

    Peptide ligands for the antigen binding site of the surface immunoglobulin receptor of a human B-cell lymphoma cell line were identified with the use of filamentous phage libraries displaying random 8- and 12-amino acid peptides. Corresponding synthetic peptides bound specifically to the antigen binding site of this immunoglobulin receptor and blocked the binding of an anti-idiotype antibody. The ligands, when conjugated to form dimers or tetramers, induced cell death by apoptosis in vitro with an IC50 between 40 and 200 nM. This effect was associated with specific stimulation of intracellular protein tyrosine phosphorylation.

    View details for Web of Science ID A1994NJ03400032

    View details for PubMedID 8170958

Stanford Medicine Resources:

Footer Links: